RCMU
THRN

Rokos Capital Management (UK)’s Thorne Healthtech, Inc. Common Stock THRN Stock Holding History

Rokos Capital Management (UK)’s Portfolio THRN Stock Details THRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-75,000
Closed -$462K – 91
2021
Q4 		$462K Sell
75,000
-75,000
-50% -$586K 0.03% 47
2021
Q3 		$1.21M Buy
+150,000
New +$1.22M 0.03% 75

Other funds holding THRN

DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
EA
Emerald Advisers Leola, Pennsylvania $3.16B AUM 109.58% 1-Year Est. Return
EMFAT
Emerald Mutual Fund Advisers Trust Leola, Pennsylvania $2.06B AUM 106.87% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SI
Scout Investments Kansas City, Missouri $3.8B AUM 45.91% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
MA
MYDA Advisors Woodmere, New York $608M AUM 77.08% 1-Year Est. Return

Rokos Capital Management (UK)'s THRN Position: Q1 2022 in Review

Rokos Capital Management (UK) sold out of Thorne Healthtech, Inc. Common Stock (THRN) in Q1 2022, closing a stake of 75,000 shares — an estimated $462K sold.

Rokos Capital Management (UK) first reported a position in THRN in Q3 2021 and held it in 2 quarters. The position peaked at $1.21M in Q3 2021. 48 funds tracked by Wall St. Rank hold THRN as of Q1 2022.

  • Rokos Capital Management (UK) reported no remaining Thorne Healthtech, Inc. Common Stock position as of Q1 2022 after selling out during the quarter.
  • Rokos Capital Management (UK) sold 75,000 Thorne Healthtech, Inc. Common Stock shares in Q1 2022, an estimated $462K.
  • Rokos Capital Management (UK) first reported a position in Thorne Healthtech, Inc. Common Stock in Q3 2021 and held it in 2 quarters.
  • Rokos Capital Management (UK)'s Thorne Healthtech, Inc. Common Stock position peaked at $1.21M in Q3 2021.
  • 48 funds tracked by Wall St. Rank held Thorne Healthtech, Inc. Common Stock as of Q1 2022.

Based on Rokos Capital Management (UK)'s 13F filing for Q1 2022, filed 16 May 2022.